Deletion of Tuberous Sclerosis Complex 1 (TSC1) in Limb Bud Mesenchyme Causes Chondrodysplasia and Severe Knee Joint Osteoarthritis in Mice

Ping-Lin Lai,Jian-Shen Lu,Xiao-Chun Bai,Dao-Zhang Cai
DOI: https://doi.org/10.21037/aoj-17-21
2020-01-01
Annals of Joint
Abstract:Background: Tuberous sclerosis complex 1/2 (TSC1/2) are key upstream negative regulators of the mechanistic target of rapamycin complex 1 (mTORC1), an emerging key regulator of skeletal growth and bone formation, but the roles of TSC in limb and joint development and function are not known. Methods: Mice with TSC1 deletion limited to limb bud mesenchymal cells were generated by crossing floxed Tsc1 mice with Prx1-Cre mice (TSC1KO). The phenotypes of limb and knee joint development in these conditional knockout mice were examined by histochemistry, immunostaining and western blotting. Results: TSC1KO mice displayed postnatal progressive expansion of chondrocytes, and much thicker growth plates compared to control mice, resulting in delayed postnatal limb development, dwarfism and chondrodysplasia. Furthermore, TSC1KO mice exhibited a phenotype of spontaneous and severe knee joint osteoarthritis (OA), characterized by loss of proteoglycan with aberrant chondrocyte proliferation and disorganization of chondrocytes in articular cartilage. Conclusions: Deletion of TSC1 in limb bud mesenchyme causes chondrodysplasia and severe knee joint OA in mice. Limb mesenchyme TSC1 is essential for normal limb and joint development and function.
What problem does this paper attempt to address?